Characteristics Without HAART
(n=100)
With HAART
(n=255)
p value
Gender   n (%)
Female
Male

52 (52.0%)
48 (48.0%)

122 (47.8%)
133 (52.2%)
 
0.4810
Ethnicity n (%)
Caucasian
No Caucasian
  67 (67.0%)
33 (33.0%)
  141(55.3%)
114 (44.7%)
0.0440
Age (years) 32.0 (26.0-42.0) 42.0 (36.0-48.0) <0.0001
Body mass index  (Kg/cm2) 24.4  (21.3-26.9) 24.2 (21.5-27.2) 0.9872
Waist circumference (cm) 89.0  (80.3-96.0) 90.0  (84.0-98.0) 0.1714
Triglycerides (mg/dL) 119.5 (78.8-160.8) 167.0 (105.0-229.0) <0.0001
Total cholesterol (mg/dL) 175.0 (152.3-193.5) 207.0 (168.0-246.0) <0.0001
LDL- cholesterol (mg/dL) 102.9 (86.3-127.5) 124.2 (93.0-152.0) 0.0003
HDL- cholesterol (mg/dL) 42.5 (35.0-49.8) 43.0 (38.0-52.0) 0.2042
TCD3+ lymphocyte (cells/µL) 1466 (939-2014) 1627 (1222-2036) 0.3673
TCD4+ lymphocyte (cells/µL) 407 (195-667) 482 (300-669) 0.2849
TCD8+ lymphocyte (cells/µL) 936 (586-1239) 1027 (748-1331) 0.2238
TCD4+/TCD8+ ratio 0.36 (0.21-0.74) 0.49 (0.29-0.68) 0.2689
HIV-1 Viral load (copies/mL) 24990 (3377-94890) <50 <0.0001
HIV-1 Viral load (log10/mL) 4.35 (3.40-4.90) <1.70 <0.0001
Chi-square test with Yates’ correction. Mann-Whitney test. Data are expressed median (25%-75%). HAART: highly active antiretroviral therapy; LDL-C: low- density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol
Table 1: Demographic, anthropometric, and biochemical characteristics of human immunodeficiency type 1 (HIV-1)-infected patients from Southern Brazil, according to the therapy.
Goto home»